Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes

NCT02490098 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding terminated

Conditions

Type 1 Diabetes

Interventions

OTHER: 6-day intervention with sensor-augmented pump therapy
OTHER: 6-day intervention with single-hormone closed-loop strategy
OTHER: 6-day intervention with dual-hormone closed-loop strategy
DRUG: Insulin
DRUG: Glucagon
DEVICE: Continuous Glucose Monitoring System Enlite sensor®, Medtronic
DEVICE: Insulin pump MiniMed® Paradigm® Veo™, Medtronic

Sponsor

Institut de Recherches Cliniques de Montreal

Collaborators

[object Object]